Researchers found the benefits of muscle relaxants and neuromodulators for treating rheumatoid arthritis pain don't outweigh the side effects, according to a news release.
Researchers looked at muscle relaxants — including benzodiazepine agents diazepam and triazolam and non- benzodiazepine agent zopiclone — and found they did not reduce pain when taken for up to two weeks, but use was associated with drowsiness and dizziness. They also looked at neuromodulators — including oral nefopam, topical capsaicin and oromucosal cannabis — and found weak evidence to support pain reduction. Use was associated with nausea, sweating, dizziness, dry mouth, light headedness, local burning and irritation.
Related Articles on Pain Management:
Will You or Your Group Participate in an ACO Arrangement in the Future? 5 Pain Management Physician Responses
Bill Would Prohibit Cash Payments in Kentucky Pain Clinics
Dr. Robert Cochran: Opiates Can Treat Bipolar Disorder
Researchers looked at muscle relaxants — including benzodiazepine agents diazepam and triazolam and non- benzodiazepine agent zopiclone — and found they did not reduce pain when taken for up to two weeks, but use was associated with drowsiness and dizziness. They also looked at neuromodulators — including oral nefopam, topical capsaicin and oromucosal cannabis — and found weak evidence to support pain reduction. Use was associated with nausea, sweating, dizziness, dry mouth, light headedness, local burning and irritation.
Related Articles on Pain Management:
Will You or Your Group Participate in an ACO Arrangement in the Future? 5 Pain Management Physician Responses
Bill Would Prohibit Cash Payments in Kentucky Pain Clinics
Dr. Robert Cochran: Opiates Can Treat Bipolar Disorder